Ascend Wellness prelim Q4 rev ~$120M, FY rev ~$500M; GTI arbitration award

Ascend Wellness Holdings, Inc.

2025-FY EPS reported -$0.58 vs consensus -$0.12 ▼ miss (-399.1%)

Q4 2025 net revenue ~$120M, Adjusted EBITDA ~$30M (25% margin); FY 2025 net revenue ~$500M, Adj EBITDA ~$117M (23% margin).
Cash and equivalents ~$86M; no significant debt maturities until 2029; liquidity sufficient for operations.
Retail footprint expanded to 47 stores; record SKUs and market share gains cited by CEO.
Arbitration award from Green Thumb Industries issued Feb 5, 2026; company disagrees, evaluating options, says has ample liquidity to satisfy if required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.